
|
![]() ![]() ![]() ![]() ![]() ![]()
Vivo Ventures is a life-sciences focused venture capital firm formed in 1996 with over $650M under management. Vivo Ventures is currently making investments from its $275M sixth fund into promising biotechnology and life science companies.
|
Recent News
Lee's Pharmaceutical Signed a Subscription Agreement with Vivo Ventures Fund
AVANIR Announces Positive Phase III Study Results for Zenvia
Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
KangHui Medical Raises Series B-1 Extension Round
APT Pharmaceuticals Secures $32 Million in Series B Financing
Sagent Completes $30 Million Series A Financing Extension |